WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010032880) KINASE INHIBITORY SUBSTANCES FOR CANCER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/032880    International Application No.:    PCT/JP2009/066864
Publication Date: 25.03.2010 International Filing Date: 18.09.2009
IPC:
A61K 31/517 (2006.01), A61K 31/4412 (2006.01), A61K 9/20 (2006.01), A61K 9/48 (2006.01), A61P 35/00 (2006.01)
Applicants: TAKEDA PHARMACEUTICAL COMPANY LIMITED [JP/JP]; 1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka 5410045 (JP) (For All Designated States Except US).
MIKI, Hiroshi [JP/JP]; (JP) (For US Only).
IWATA, Hidehisa [JP/JP]; (JP) (For US Only)
Inventors: MIKI, Hiroshi; (JP).
IWATA, Hidehisa; (JP)
Agent: TAKASHIMA, Hajime; Meiji Yasuda Seimei Osaka Midosuji Bldg., 1-1, Fushimimachi 4-chome, Chuo-ku, Osaka-shi, Osaka 5410044 (JP)
Priority Data:
2008-241729 19.09.2008 JP
61/150,180 05.02.2009 US
Title (EN) KINASE INHIBITORY SUBSTANCES FOR CANCER
(FR) AGENT PROPHYLACTIQUE/THÉRAPEUTIQUE POUR LE CANCER
Abstract: front page image
(EN)The present invention provides an agent for the prophylaxis or treatment cancer, which is superior in the safety and the like. An agent for the prophylaxis or treatment cancer, which contains a kinase inhibitory substance showing pseudo-irreversibility, particularly, an agent for the prophylaxis or treatment cancer, which contains a kinase inhibitory substance showing t1/2 relative to kinase (receptor kinase etc.) of not less than 10 minutes.
(FR)La présente invention concerne un agent pour la prophylaxie ou le traitement du cancer, qui est supérieur en termes de sécurité et similaire. L'agent pour la prophylaxie ou le traitement du cancer contient une substance inhibitrice de kinase présentant une pseudo-irréversibilité, en particulier, l'agent pour la prophylaxie ou le traitement du cancer contient une substance inhibitrice de kinase présentant un t1/2 par rapport à une kinase (récepteur kinase, etc.) de pas moins de 10 minutes.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)